The modern treatment of cardiovascular diseases with b-blockers - focus on the nebivolol.
Unlike first-line antihypertensives, nebivolol, a cardioselective b-blocker with vasodilatatory properties caused by its ability to modulate the activity of nitric oxide, positively affects prognosis in patients with arterial hypertension and chronic heart failure and shows metabolic neutrality. The...
| Váldodahkkit: | , , , , |
|---|---|
| Materiálatiipa: | Artihkal |
| Giella: | Russian |
| Almmustuhtton: |
IP Morozov P.V.
2009-12-01
|
| Ráidu: | Системные гипертензии |
| Fáttát: | |
| Liŋkkat: | https://syst-hypertension.ru/2075-082X/article/view/33077 |
| _version_ | 1828769647374106624 |
|---|---|
| author | Anna Grigor'evna Evdokimova Valeriy Aleksandrovich Ol'khin Vladimir Vyacheslavovich Evdokimov Ekaterina Viktorovna Zolotareva Alla Blalovna Khadzegova |
| author_facet | Anna Grigor'evna Evdokimova Valeriy Aleksandrovich Ol'khin Vladimir Vyacheslavovich Evdokimov Ekaterina Viktorovna Zolotareva Alla Blalovna Khadzegova |
| author_sort | Anna Grigor'evna Evdokimova |
| collection | DOAJ |
| description | Unlike first-line antihypertensives, nebivolol, a cardioselective b-blocker with vasodilatatory properties caused by its ability to modulate the activity of nitric oxide, positively affects prognosis in patients with arterial hypertension and chronic heart failure and shows metabolic neutrality. The clinical and pathogenetic studies demonstrating the benefits of nebivolol are discussed.
Keywords: nebivolol, arterial hypertension, b-blockers. |
| first_indexed | 2024-12-11T13:51:53Z |
| format | Article |
| id | doaj.art-c0988868fc9641c0b6fb3b25ad432208 |
| institution | Directory Open Access Journal |
| issn | 2075-082X 2542-2189 |
| language | Russian |
| last_indexed | 2024-12-11T13:51:53Z |
| publishDate | 2009-12-01 |
| publisher | IP Morozov P.V. |
| record_format | Article |
| series | Системные гипертензии |
| spelling | doaj.art-c0988868fc9641c0b6fb3b25ad4322082022-12-22T01:04:14ZrusIP Morozov P.V.Системные гипертензии2075-082X2542-21892009-12-0164202529818The modern treatment of cardiovascular diseases with b-blockers - focus on the nebivolol.Anna Grigor'evna EvdokimovaValeriy Aleksandrovich Ol'khinVladimir Vyacheslavovich EvdokimovEkaterina Viktorovna ZolotarevaAlla Blalovna KhadzegovaUnlike first-line antihypertensives, nebivolol, a cardioselective b-blocker with vasodilatatory properties caused by its ability to modulate the activity of nitric oxide, positively affects prognosis in patients with arterial hypertension and chronic heart failure and shows metabolic neutrality. The clinical and pathogenetic studies demonstrating the benefits of nebivolol are discussed. Keywords: nebivolol, arterial hypertension, b-blockers.https://syst-hypertension.ru/2075-082X/article/view/33077небивололартериальная гипертензияb-блокаторы |
| spellingShingle | Anna Grigor'evna Evdokimova Valeriy Aleksandrovich Ol'khin Vladimir Vyacheslavovich Evdokimov Ekaterina Viktorovna Zolotareva Alla Blalovna Khadzegova The modern treatment of cardiovascular diseases with b-blockers - focus on the nebivolol. Системные гипертензии небиволол артериальная гипертензия b-блокаторы |
| title | The modern treatment of cardiovascular diseases with b-blockers - focus on the nebivolol. |
| title_full | The modern treatment of cardiovascular diseases with b-blockers - focus on the nebivolol. |
| title_fullStr | The modern treatment of cardiovascular diseases with b-blockers - focus on the nebivolol. |
| title_full_unstemmed | The modern treatment of cardiovascular diseases with b-blockers - focus on the nebivolol. |
| title_short | The modern treatment of cardiovascular diseases with b-blockers - focus on the nebivolol. |
| title_sort | modern treatment of cardiovascular diseases with b blockers focus on the nebivolol |
| topic | небиволол артериальная гипертензия b-блокаторы |
| url | https://syst-hypertension.ru/2075-082X/article/view/33077 |
| work_keys_str_mv | AT annagrigorevnaevdokimova themoderntreatmentofcardiovasculardiseaseswithbblockersfocusonthenebivolol AT valeriyaleksandrovicholkhin themoderntreatmentofcardiovasculardiseaseswithbblockersfocusonthenebivolol AT vladimirvyacheslavovichevdokimov themoderntreatmentofcardiovasculardiseaseswithbblockersfocusonthenebivolol AT ekaterinaviktorovnazolotareva themoderntreatmentofcardiovasculardiseaseswithbblockersfocusonthenebivolol AT allablalovnakhadzegova themoderntreatmentofcardiovasculardiseaseswithbblockersfocusonthenebivolol AT annagrigorevnaevdokimova moderntreatmentofcardiovasculardiseaseswithbblockersfocusonthenebivolol AT valeriyaleksandrovicholkhin moderntreatmentofcardiovasculardiseaseswithbblockersfocusonthenebivolol AT vladimirvyacheslavovichevdokimov moderntreatmentofcardiovasculardiseaseswithbblockersfocusonthenebivolol AT ekaterinaviktorovnazolotareva moderntreatmentofcardiovasculardiseaseswithbblockersfocusonthenebivolol AT allablalovnakhadzegova moderntreatmentofcardiovasculardiseaseswithbblockersfocusonthenebivolol |